0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-26U25
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Flu Vaccine Influenza Vaccine Market Insights Forecast to 2025

Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025

Code: QYRE-Auto-26U25
Report
May 2019
111 Pages
QYResearch
Region: Global, Europe, Germany, France, EMEA, North America, Central & South America, Asia Pacific, Middle East, Africa, Russia,
Description
Table of Content
Tables & Figures
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016. Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%. The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
The global Flu Vaccine (Influenza Vaccine) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Flu Vaccine (Influenza Vaccine) market based on company, product type, end user and key regions.

This report studies the global market size of Flu Vaccine (Influenza Vaccine) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Flu Vaccine (Influenza Vaccine) in these regions.
This research report categorizes the global Flu Vaccine (Influenza Vaccine) market by top players/brands, region, type and end user. This report also studies the global Flu Vaccine (Influenza Vaccine) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    CSL
    GSK
    Sanofi Pasteur
    Mylan
    AstraZeneca
    Pfizer
    Johnson & Johnson

Market size by Product
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Vaccines
    Live Attenuated Virus Vaccines
Market size by End User
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Flu Vaccine (Influenza Vaccine) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Flu Vaccine (Influenza Vaccine) market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Flu Vaccine (Influenza Vaccine) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Flu Vaccine (Influenza Vaccine) submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Flu Vaccine (Influenza Vaccine) are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Flu Vaccine (Influenza Vaccine) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Flu Vaccine (Influenza Vaccine) Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by Product
        1.4.2 Whole Virus Vaccines
        1.4.3 Split Virus Vaccines
        1.4.4 Subunit Vaccines
        1.4.5 Live Attenuated Virus Vaccines
    1.5 Market by End User
        1.5.1 Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by End User
        1.5.2 For Children (6 months to 3 years)
        1.5.3 For Adults and Children over 3 years
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Flu Vaccine (Influenza Vaccine) Market Size
        2.1.1 Global Flu Vaccine (Influenza Vaccine) Revenue 2014-2025
        2.1.2 Global Flu Vaccine (Influenza Vaccine) Sales 2014-2025
    2.2 Flu Vaccine (Influenza Vaccine) Growth Rate by Regions
        2.2.1 Global Flu Vaccine (Influenza Vaccine) Sales by Regions
        2.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Flu Vaccine (Influenza Vaccine) Sales by Manufacturers
        3.1.1 Flu Vaccine (Influenza Vaccine) Sales by Manufacturers
        3.1.2 Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturers
        3.1.3 Global Flu Vaccine (Influenza Vaccine) Market Concentration Ratio (CR5 and HHI)
    3.2 Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers
        3.2.1 Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2014-2019)
        3.2.2 Flu Vaccine (Influenza Vaccine) Revenue Share by Manufacturers (2014-2019)
    3.3 Flu Vaccine (Influenza Vaccine) Price by Manufacturers
    3.4 Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution, Product Types
        3.4.1 Flu Vaccine (Influenza Vaccine) Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Flu Vaccine (Influenza Vaccine) Product Type
        3.4.3 Date of International Manufacturers Enter into Flu Vaccine (Influenza Vaccine) Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Flu Vaccine (Influenza Vaccine) Sales by Product
    4.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Product
    4.3 Flu Vaccine (Influenza Vaccine) Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Flu Vaccine (Influenza Vaccine) Breakdown Data by End User

6 North America
    6.1 North America Flu Vaccine (Influenza Vaccine) by Countries
        6.1.1 North America Flu Vaccine (Influenza Vaccine) Sales by Countries
        6.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Flu Vaccine (Influenza Vaccine) by Product
    6.3 North America Flu Vaccine (Influenza Vaccine) by End User

7 Europe
    7.1 Europe Flu Vaccine (Influenza Vaccine) by Countries
        7.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales by Countries
        7.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Flu Vaccine (Influenza Vaccine) by Product
    7.3 Europe Flu Vaccine (Influenza Vaccine) by End User

8 Asia Pacific
    8.1 Asia Pacific Flu Vaccine (Influenza Vaccine) by Countries
        8.1.1 Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries
        8.1.2 Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Flu Vaccine (Influenza Vaccine) by Product
    8.3 Asia Pacific Flu Vaccine (Influenza Vaccine) by End User

9 Central & South America
    9.1 Central & South America Flu Vaccine (Influenza Vaccine) by Countries
        9.1.1 Central & South America Flu Vaccine (Influenza Vaccine) Sales by Countries
        9.1.2 Central & South America Flu Vaccine (Influenza Vaccine) Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Flu Vaccine (Influenza Vaccine) by Product
    9.3 Central & South America Flu Vaccine (Influenza Vaccine) by End User

10 Middle East and Africa
    10.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries
        10.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries
        10.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Product
    10.3 Middle East and Africa Flu Vaccine (Influenza Vaccine) by End User

11 Company Profiles
    11.1 CSL
        11.1.1 CSL Company Details
        11.1.2 Company Business Overview
        11.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 CSL Flu Vaccine (Influenza Vaccine) Products Offered
        11.1.5 CSL Recent Development
    11.2 GSK
        11.2.1 GSK Company Details
        11.2.2 Company Business Overview
        11.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 GSK Flu Vaccine (Influenza Vaccine) Products Offered
        11.2.5 GSK Recent Development
    11.3 Sanofi Pasteur
        11.3.1 Sanofi Pasteur Company Details
        11.3.2 Company Business Overview
        11.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Products Offered
        11.3.5 Sanofi Pasteur Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Details
        11.4.2 Company Business Overview
        11.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Mylan Flu Vaccine (Influenza Vaccine) Products Offered
        11.4.5 Mylan Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 Company Business Overview
        11.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 AstraZeneca Flu Vaccine (Influenza Vaccine) Products Offered
        11.5.5 AstraZeneca Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Company Business Overview
        11.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Pfizer Flu Vaccine (Influenza Vaccine) Products Offered
        11.6.5 Pfizer Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Details
        11.7.2 Company Business Overview
        11.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Products Offered
        11.7.5 Johnson & Johnson Recent Development

12 Future Forecast
    12.1 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions
        12.1.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Regions 2019-2025
        12.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Regions 2019-2025
    12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Product
        12.2.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Product 2019-2025
        12.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Product 2019-2025
    12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by End User
    12.4 North America Flu Vaccine (Influenza Vaccine) Forecast
    12.5 Europe Flu Vaccine (Influenza Vaccine) Forecast
    12.6 Asia Pacific Flu Vaccine (Influenza Vaccine) Forecast
    12.7 Central & South America Flu Vaccine (Influenza Vaccine) Forecast
    12.8 Middle East and Africa Flu Vaccine (Influenza Vaccine) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Flu Vaccine (Influenza Vaccine) Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Flu Vaccine (Influenza Vaccine) Product Picture
    Table Flu Vaccine (Influenza Vaccine) Market Segments
    Table Key Manufacturers Flu Vaccine (Influenza Vaccine) Covered
    Table Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
    Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Product 2014-2025
    Figure Whole Virus Vaccines Product Picture
    Table Major Manufacturers of Whole Virus Vaccines
    Figure Split Virus Vaccines Product Picture
    Table Major Manufacturers of Split Virus Vaccines
    Figure Subunit Vaccines Product Picture
    Table Major Manufacturers of Subunit Vaccines
    Figure Live Attenuated Virus Vaccines Product Picture
    Table Major Manufacturers of Live Attenuated Virus Vaccines
    Table Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by End User 2019-2025 (K Doses)
    Figure For Children (6 months to 3 years)
    Figure For Adults and Children over 3 years
    Figure Flu Vaccine (Influenza Vaccine) Report Years Considered
    Figure Global Flu Vaccine (Influenza Vaccine) Market Size 2014-2025 (Million US$)
    Figure Global Flu Vaccine (Influenza Vaccine) Sales 2014-2025 (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Market Size by Regions 2014-2019 (K Doses) & (Million US$)
    Table Global Flu Vaccine (Influenza Vaccine) Sales by Regions 2014-2019 (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions 2014-2019
    Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions 2014-2019
    Figure 2018 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Regions
    Table Global Flu Vaccine (Influenza Vaccine) Revenue by Regions 2014-2019 (Million US$)
    Table Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions 2014-2019
    Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Regions
    Table Global Flu Vaccine (Influenza Vaccine) Sales by Manufacturers (2014-2019) (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Manufacturers (2014-2019)
    Figure Global Flu Vaccine (Influenza Vaccine) Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2014-2019) (Million USD)
    Table Flu Vaccine (Influenza Vaccine) Revenue Share by Manufacturers (2014-2019)
    Figure Flu Vaccine (Influenza Vaccine) Value Share by Manufacturers in 2018
    Table Key Manufacturers Flu Vaccine (Influenza Vaccine) Price (2014-2019) (USD/Doses)
    Table Flu Vaccine (Influenza Vaccine) Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Flu Vaccine (Influenza Vaccine) Product Type
    Table Date of International Manufacturers Enter into Flu Vaccine (Influenza Vaccine) Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Flu Vaccine (Influenza Vaccine) Sales by Product (2014-2019) (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Share by Product (2014-2019)
    Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Product (2014-2019)
    Figure Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Product in 2018
    Table Global Flu Vaccine (Influenza Vaccine) Revenue by Product (2014-2019) (Million US$)
    Table Global Flu Vaccine (Influenza Vaccine) Revenue Share by Product (2014-2019)
    Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Product (2014-2019)
    Figure Global Flu Vaccine (Influenza Vaccine) Revenue Market Share by Product in 2018
    Table Flu Vaccine (Influenza Vaccine) Price by Product 2014-2019 (USD/Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales by End User (2014-2019) (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Share by End User (2014-2019)
    Figure Global Sales Flu Vaccine (Influenza Vaccine) Market Share by End User (2014-2019)
    Figure Global Sales Flu Vaccine (Influenza Vaccine) Market Share by End User in 2018
    Figure North America Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2014-2019 (K Doses)
    Figure North America Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019) (K Doses)
    Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
    Table North America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019) (Million US$)
    Table North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
    Figure United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure United States Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (K Doses)
    Figure Canada Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Canada Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Mexico Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Flu Vaccine (Influenza Vaccine) Sales by Product (2014-2019) (K Doses)
    Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by Product (2014-2019)
    Figure 2018 North America Flu Vaccine (Influenza Vaccine) Market Share by Product
    Table North America Flu Vaccine (Influenza Vaccine) Sales by End User (2014-2019) (K Doses)
    Table North America Flu Vaccine (Influenza Vaccine) Sales Market Share by End User (2014-2019)
    Figure 2018 North America Flu Vaccine (Influenza Vaccine) Market Share by End User
    Figure Europe Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2014-2019 (K Doses)
    Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019) (K Doses)
    Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
    Table Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019) (Million US$)
    Table Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
    Figure Germany Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Germany Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure France Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure UK Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Italy Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Russia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Flu Vaccine (Influenza Vaccine) Sales by Product (2014-2019) (K Doses)
    Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Flu Vaccine (Influenza Vaccine) Market Share by Product
    Table Europe Flu Vaccine (Influenza Vaccine) Sales by End User (2014-2019) (K Doses)
    Table Europe Flu Vaccine (Influenza Vaccine) Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Flu Vaccine (Influenza Vaccine) Market Share by End User
    Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2014-2019 (K Doses)
    Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019) (K Doses)
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
    Figure China Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure China Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Japan Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Korea Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure India Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Australia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Indonesia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Malaysia Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Philippines Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Thailand Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Vietnam Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Singapore Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Product (2014-2019) (K Doses)
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Flu Vaccine (Influenza Vaccine) Market Share by Product
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by End User (2014-2019) (K Doses)
    Table Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Flu Vaccine (Influenza Vaccine) Market Share by End User
    Figure Central & South America Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2014-2019 (K Doses)
    Figure Central & South America Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019) (K Doses)
    Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
    Table Central & South America Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
    Figure Brazil Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Brazil Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Argentina Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by Product (2014-2019) (K Doses)
    Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Flu Vaccine (Influenza Vaccine) Market Share by Product
    Table Central & South America Flu Vaccine (Influenza Vaccine) Sales by End User (2014-2019) (K Doses)
    Table Central & South America Flu Vaccine (Influenza Vaccine) Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Flu Vaccine (Influenza Vaccine) Market Share by End User
    Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Growth Rate 2014-2019 (K Doses)
    Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries (2014-2019) (K Doses)
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Countries
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Market Share by Countries
    Figure GCC Countries Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure GCC Countries Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Turkey Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure Egypt Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2014-2019) (K Doses)
    Figure South Africa Flu Vaccine (Influenza Vaccine) Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Product (2014-2019) (K Doses)
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Share by Product
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by End User (2014-2019) (K Doses)
    Table Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Share by End User
    Table CSL Company Details
    Table CSL Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table CSL Recent Development
    Table GSK Company Details
    Table GSK Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table GSK Recent Development
    Table Sanofi Pasteur Company Details
    Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Sanofi Pasteur Recent Development
    Table Mylan Company Details
    Table Mylan Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Mylan Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table AstraZeneca Recent Development
    Table Pfizer Company Details
    Table Pfizer Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Pfizer Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019)
    Table Johnson & Johnson Recent Development
    Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Regions 2019-2025 (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share Forecast by Regions 2019-2025
    Table Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Flu Vaccine (Influenza Vaccine) Revenue Market Share Forecast by Regions 2019-2025
    Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Product 2019-2025 (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share Forecast by Product 2019-2025
    Table Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Flu Vaccine (Influenza Vaccine) Revenue Market Share Forecast by Product 2019-2025
    Table Global Flu Vaccine (Influenza Vaccine) Sales Forecast by End User 2019-2025 (K Doses)
    Table Global Flu Vaccine (Influenza Vaccine) Sales Market Share Forecast by End User 2019-2025
    Figure North America Flu Vaccine (Influenza Vaccine) Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure North America Flu Vaccine (Influenza Vaccine) Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Flu Vaccine (Influenza Vaccine) Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Europe Flu Vaccine (Influenza Vaccine) Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Flu Vaccine (Influenza Vaccine) Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Central & South America Flu Vaccine (Influenza Vaccine) Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Flu Vaccine (Influenza Vaccine) Value Chain
    Table Flu Vaccine (Influenza Vaccine) Customers List
    Table Flu Vaccine (Influenza Vaccine) Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Valacyclovir API Market Research Report 2022
Global Valacyclovir API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-8W11843
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Helicobacter Pylori Rapid Testing Market Research Report 2022
Global Helicobacter Pylori Rapid Testing Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-5Y11620
Wed Aug 10 00:00:00 UTC 2022

Add to Cart

Global Tuberculosis Infection Detection Kit Market Research Report 2022
Global Tuberculosis Infection Detection Kit Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-25G11469
Wed Aug 10 00:00:00 UTC 2022

Add to Cart

Global Viral Vectors Gene Therapy Market Research Report 2022
Global Viral Vectors Gene Therapy Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-23K11342
Mon Aug 08 00:00:00 UTC 2022

Add to Cart